GCP
TELA icon

GSA Capital Partners’s TELA Bio TELA Stock Holding History

GSA Capital Partners’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73,811
Closed -$87K – 2149
2025
Q4 		$87K Sell
73,811
-31,998
-30% -$40.5K 0.01% 1546
2025
Q3 		$158K Buy
105,809
+54,613
+107% +$96.2K 0.01% 1473
2025
Q2 		$99K Buy
51,196
+10,532
+26% +$13.8K 0.01% 1615
2025
Q1 		$50K Sell
40,664
-95,090
-70% -$234K ﹤0.01% 1547
2024
Q4 		$410K Buy
135,754
+23,549
+21% +$66.2K 0.03% 1020
2024
Q3 		$284K Buy
112,205
+89,712
+399% +$319K 0.02% 1247
2024
Q2 		$106K Sell
22,493
-1,892
-8% -$9.97K 0.01% 1526
2024
Q1 		$138K Buy
+24,385
New +$161K 0.01% 1460

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

GSA Capital Partners's TELA Position: Q1 2026 in Review

GSA Capital Partners sold out of TELA Bio (TELA) in Q1 2026, closing a stake of 73,811 shares — an estimated $87K sold.

GSA Capital Partners first reported a position in TELA in Q1 2024 and held it in 8 quarters. The position peaked at $410K in Q4 2024. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

  • GSA Capital Partners reported no remaining TELA Bio position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 73,811 TELA Bio shares in Q1 2026, an estimated $87K.
  • GSA Capital Partners first reported a position in TELA Bio in Q1 2024 and held it in 8 quarters.
  • GSA Capital Partners's TELA Bio position peaked at $410K in Q4 2024.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.